CPC Launches Industry-First Product for Cell and Gene Therapy Sterile Processing

Core Insights - CPC has launched the MicroCNX® Nano Series aseptic connectors aimed at simplifying closed sterile processing in cell and gene therapy (CGT) [1][2] - The new connectors allow for easier assembly of sterile flow paths, moving away from older techniques like tube welding, which can create holdup volume [2][3] - The MicroCNX Nano connectors can withstand freezing temperatures down to -190°C, supporting cell health during storage and transport [3] Company Overview - CPC (Colder Products Company) is a leader in single-use connection technology for biopharmaceuticals, cell therapy, and gene therapy [5] - The company offers a variety of connectors that enhance production yields, reduce time to market, and maintain media sterility [5] - CPC is part of Dover Corporation, which has an annual revenue exceeding $7 billion and operates across multiple segments [6]